“Usage occasions” are a key growth driver for Kenvue Inc.’s portfolio of consumer health products, says its CEO.
“You are not competing for a fixed share of calories or a fixed share of number of times of having...
Consumers Know Kenvue's Brands, But What About ‘Opportunity To Expand Usage Occasions’?
Listen to this article
“That’s what makes this space very attractive, the ability to expand usage occasions to give consumers around the world new opportunities to take care of their health,” says CEO Thibaut Mongon. Some investors aren’t clear on what to expect from company operating entirely in consumer health since spinout from J&J.
Explore how consumer health is evolving. On the go.
More from Strategy
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
• By
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
• By
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
• By
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
More from Business
• By
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
• By
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.